Maccura Biotechnology Co.Ltd (SHE:300463)

Market Cap	7.29B -6.5%
Revenue (ttm)	2.21B -19.0%
Net Income	-117.46M
EPS	-0.19
Shares Out	604.67M
PE Ratio	n/a
Forward PE	30.13
Dividend	0.10 (0.87%)
Ex-Dividend Date	May 28, 2025

Volume	13,514,137
Average Volume	20,959,952
Open	12.28
Previous Close	12.05
Day's Range	11.90 - 12.28
52-Week Range	10.90 - 15.40
Beta	0.29
RSI	50.62
Earnings Date	Apr 29, 2026

About SHE:300463

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1994
• Employees: 3,106
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300463

Financial Performance

In 2024, SHE:300463's revenue was 2.55 billion, a decrease of -11.98% compared to the previous year's 2.90 billion. Earnings were 126.81 million, a decrease of -59.44%.